PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Phenotype | |hepatocellular carcinoma |
| Sentences | 124 |
| PubMedID- 25743000 | Objective: to determine the impact of phlebotomy on the laboratory values and the incidence of hepatocellular carcinoma (hcc) in patients with hepatitis c. |
| PubMedID- 26508201 | Characteristics and prognosis of hepatocellular carcinoma detected in patients with chronic hepatitis c after the eradication of hepatitis c virus: a multicenter study from japan. |
| PubMedID- 22615799 | Similarly, hepatitis c infections are strongly associated with hepatocellular carcinomas, and schistosomiasis is a major cause of bladder cancer [12]. |
| PubMedID- 21766498 | Purpose: the aim of this study was to compare patients with hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection with patients with liver cirrhosis associated with hcv virus infection. |
| PubMedID- 26064707 | His medical history was notable for cirrhosis secondary to chronic hepatitis c, complicated by multifocal hepatocellular carcinoma (hcc), which had been lately diagnosed following an episode of obstructive jaundice. |
| PubMedID- 20087166 | hepatitis c prevalence in patients with hepatocellular carcinoma without cirrhosis. |
| PubMedID- 24677195 | hepatocellular carcinoma screening in patients with compensated hepatitis c virus (hcv)-related cirrhosis aware of their hcv status improves survival: a modeling approach. |
| PubMedID- 21374690 | Previous studies have suggested that prior exposure to hepatitis b virus (hbv) infection may increase the risk of development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |
| PubMedID- 25650331 | Purpose: to evaluate whether a hepatic fibrosis index (hfi), quantified on the basis of hepatic contour abnormality, is a risk factor for the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |
| PubMedID- 20616578 | Impact of peginterferon maintenance therapy on the risk of developing hepatocellular carcinoma in patients with chronic hepatitis c virus. |
| PubMedID- 22207106 | Randomized controlled trials also confirm that glycyrrhizin and its derivatives can improve the hepatocellular injury in chronic hepatitis b or c patients, and reduce the risk for hepatocellular carcinoma in patients with hepatitis c virus-induced cirrhosis [12]. |
| PubMedID- 22588449 | Skull metastasis from hepatocellular carcinoma with hepatitis c. |
| PubMedID- 21610221 | Background: this study explores the influence of two functional genetic polymorphisms in the regulated on activation in normal t-cell expressed and secreted(rantes) promoter on the risk of hepatocellular carcinoma (hcc) occurrence in patients with alcoholic or hepatitis c virus (hcv)-related cirrhosis. |
| PubMedID- 22911171 | Methods: thirty-eight patients who underwent hepatectomy for hepatocellular carcinoma (hcc) with hepatitis c virus infection were included. |
| PubMedID- 22363173 | We observed a strong correlation between hepatic 8-oxodg staining and serum ferritin levels, suggesting the iron content to be a strong mediator of oxidative stress and iron reduction to reduce the incidence of hepatocellular carcinoma in patients with chronic hepatitis c [57, 58]. |
| PubMedID- 25657603 | In a recent report from our institution, we identified over a three-year period 3% (9/298) of ltx patients who developed severe hf after ltx.62 in these nine patients, etiology of liver failure was hepatitis c with hepatocellular carcinoma in four, hemochromatosis in four (with one showing evidence of iron deposition in the heart on biopsy), and one with primary biliary cirrhosis. |
| PubMedID- 26070204 | Serum wisteria floribunda agglutinin-positive mac-2 binding protein values predict the development of hepatocellular carcinoma among patients with chronic hepatitis c after sustained virological response. |
| PubMedID- 20521755 | The american association for the study of liver diseases recommends ultrasound surveillance for hepatocellular carcinoma in persons with chronic hepatitis c virus infection and cirrhosis. |
| PubMedID- 26519622 | The updated model: an adjusted serum alpha-fetoprotein-based algorithm for hepatocellular carcinoma detection with hepatitis c virus-related cirrhosis. |
| PubMedID- 23426277 | Association of interleukin-28b genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis c. |
| PubMedID- 24632756 | The serum level of vegf has potential to be a useful predictor of the presence of hepatocellular carcinoma in patients with hepatitis c virus (hcv)-related liver cirrhosis, while serum levels of afp and vegf can predict tumor type and vascular invasion, respectively25. |
| PubMedID- 26140089 | Aim: to evaluate the downstaging rates in hepatitis c virus-patients with hepatocellular carcinoma (hcc), treated with degradable starch microspheres transcatheter arterial chemoembolization (dsm-tace), to reach new-milan-criteria (nmc) for transplantation. |
| PubMedID- 26045707 | Conclusions: sustained virological response can reduce all-cause mortality and the incidence of hepatocellular carcinoma of patients with hepatitis c. |
| PubMedID- 25373121 | Are selective serotonin reuptake inhibitors associated with hepatocellular carcinoma in patients with hepatitis c. |